Publications & Resources

Dental amalgam is “durable, safe and effective” despite containing mercury, the American Dental Association reaffirmed, responding to a recent statement by the Food and Drug Administration.

The FDA cautions that a number of websites are illegally selling unauthorized opioids that may be counterfeit, contaminated, expired or otherwise unsafe.

FDA is cautioning healthcare providers about an increase in hand sanitizer products contaminated with methanol, a substance that can be toxic when absorbed through the skin or life-threatening when ingested.

New research indicates there is weak evidence that chloroquine, hydroxychloroquine and azithromycin can effectively treat and prevent COVID-19 and the drugs carry potentially serious risks.

The FDA issued emergency use authorization for anti-malarial drugs hydroxychloroquine and chloroquine to treat COVID-19 patients when deemed appropriate by a healthcare provider.

The FDA has updated guidance on which medical devices are regulated by the agency.

The FDA warns manufacturers, healthcare providers, hospitals and patients that the “URGENT/11” security flaws may cause medical devices to malfunction.

The FDA updates physicians about adverse events associated with surgical staplers and implantable surgical staples and provides recommendations for improving patient safety.

Effective January 18, 2017, the FDA has banned the use of powdered gloves in healthcare. MLMIC recommends that all insureds protect their patients and ensure their practices are in compliance.

MLMIC believes in helping our insureds understand and gain access to current information impacting the health and safety of patients.